Exchange-based private market platforms are live. Why most investors in Asia still can't access anything worth buying.
Licensed exchange infrastructure for private market securities is operating across Asia. The Labuan FSA has licensed its fifth digital exchange. The Philippines SEC's securities exchange framework is running. Hong Kong's SFC has a mandatory licensing regime for trading platforms. Singapore's MAS has its managed framework in place.
For a retail investor in Kuala Lumpur or Manila: what can you actually invest in today? The honest answer is still almost nothing.
Regulatory infrastructure and investable products are not the same thing. What's missing is the origination and distribution layer that connects the framework to deals that real investors can access at meaningful minimums.
Where the problem actually sits
Most exchange-listed private market products are designed for institutional participants: US Treasuries, money market instruments, and government bonds structured for institutional liquidity management. These solve a problem that banks and large funds have — settlement efficiency, collateral management, yield on short-duration holdings. They do not solve the problem that a retail investor in Hong Kong or Jakarta has, which is access to the asset classes — private credit, pre-IPO equity, infrastructure — that generate returns the public market stopped offering.
The exchange infrastructure is necessary. It is not sufficient.
What's missing — and who's building it
Two things separate available infrastructure from accessible deals: licensed platforms willing to operate at retail minimums, and credible deal origination at institutional quality. The first exists. The second is harder. Originating, underwriting, and managing private credit and pre-IPO equity deals at scale requires a different operating model than running an exchange licence.
That's the distinction between an infrastructure business and a capital markets participant. We are the latter. The exchange infrastructure is how we deliver — it is not the product.
This article is market commentary and does not constitute investment advice. Exchange licensing details reflect publicly available regulatory information as of July 2026.